Factory jobs are scarce but crucial-The rest of the story |The Tennessean

Leave a comment

There are so few of them, they can be difficult to recall.

There is the Nu-kote facility. Lasko Metal Products is another and there is Apcom, which makes thermostats and other parts for water heaters and employs about 285 people.

With only 3 percent of Williamson County’s economy dedicated to manufacturing, the list of companies here that produce a tangible product is short. The three companies already mentioned are among the biggest manufacturing employers in a county where professional services and trade companies dominate the job market.

via Factory jobs are scarce but crucial | tennessean.com | The Tennessean.

The main problem with this article is that there is such a narrow understanding of what manufacturing and production can really mean.  Just look down the road 80 miles and you will see Huntsville and many types of higher and high tech manufacturing facilties.  Even more, there is a hidden gem not mentioned in this article, Biomimetic Therapeutics, another type of production facility in a much higher value-added production world, life science.

If we are going to have an educated discussion about production, let’s at least talk about what is possible, not what people have done for years that is better produced in a low wage environment.

BioMimetic Therapeutics Reports 2010 Second Quarter Earnings Results – MarketWatch

Leave a comment

BioMimetic Therapeutics, Inc. (BMTI 9.55, -0.13, -1.34%) today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009. The Company ended the quarter with $60.7 million of cash and cash equivalents and investments.

via BioMimetic Therapeutics Reports 2010 Second Quarter Earnings Results – MarketWatch.

I would still keep BioMimetic Therapeutics on my list of firms to watch and invest in.